Literature DB >> 10503259

Sarcomatoid renal carcinoma: the final common dedifferentiation pathway of renal epithelial malignancies.

B Delahunt1.   

Abstract

Sarcomatoid renal carcinoma (SRC) is an aggressive neoplasm with an age and gender distribution similar to that of conventional (clear cell) renal cell carcinoma (RCC). Genetic and morphologic evidence indicates that the tumor results from de-differentiation of renal epithelial malignancy and associations with RCC, papillary renal carcinoma, chromophobe renal carcinoma and collecting duct carcinoma have been reported. The tumor is composed of sheets of malignant spindle cells that have immunohistochemical and ultrastructural features of both stromal and epithelial cells, and may contain myxoid areas containing osteoclast-like giant cells or pleomorphic sarcomatoid spindle cells resembling rhabdomyoblasts. Rare cases of osteogenic SRC have been described. The tumor shows marked proliferative activity in growth kinetic studies and is usually associated with a poor patient survival that is best predicted by staging.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10503259     DOI: 10.1080/003130299104945

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  30 in total

1.  Cytoreductive nephrectomy for kidney cancer with sarcomatoid histology--is up-front resection indicated and, if not, is it avoidable?

Authors:  Brian Shuch; Jonathan Said; Jeff C La Rochelle; Ying Zhou; Gang Li; Tobias Klatte; Fairooz F Kabbinaavar; Allan J Pantuck; Arie S Belldegrun
Journal:  J Urol       Date:  2009-09-16       Impact factor: 7.450

2.  Percentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiation.

Authors:  Mehrad Adibi; Arun Z Thomas; Leonardo D Borregales; Megan M Merrill; Rebecca S Slack; Hsiang-Chun Chen; Kanishka Sircar; Paari Murugan; Pheroze Tamboli; Eric Jonasch; Nizar M Tannir; Surena F Matin; Christopher G Wood; Jose A Karam
Journal:  Urol Oncol       Date:  2015-05-23       Impact factor: 3.498

3.  Temsirolimus in renal cell carcinoma with sarcomatoid differentiation: a report of three cases.

Authors:  Maria Carmen Areses; Urbano Anido Herranz; Beatriz Bernárdez Ferrán; Luis León Mateos; Jorge Garcia González; Rafael López López
Journal:  Med Oncol       Date:  2011-05-11       Impact factor: 3.064

4.  Sarcomatoid renal cell carcinoma: genomic insights from sequencing of matched sarcomatous and carcinomatous components.

Authors:  Brandon J Manley; James J Hsieh
Journal:  Transl Cancer Res       Date:  2016-08       Impact factor: 1.241

5.  Histologic evaluation of metastases in renal cell carcinoma with sarcomatoid transformation and its implications for systemic therapy.

Authors:  Brian Shuch; Jonathan Said; Jeffrey C LaRochelle; Ying Zhou; Gang Li; Tobias Klatte; Frederic Pouliot; Fairooz F Kabbinavar; Arie S Belldegrun; Allan J Pantuck
Journal:  Cancer       Date:  2010-02-01       Impact factor: 6.860

6.  Phase 2 Trial of Capecitabine, Gemcitabine, and Bevacizumab in Sarcomatoid Renal-Cell Carcinoma.

Authors:  Abhishek Maiti; Maryam Nemati-Shafaee; Pavlos Msaouel; Lance C Pagliaro; Eric Jonasch; Nizar M Tannir; Amishi Y Shah
Journal:  Clin Genitourin Cancer       Date:  2017-08-10       Impact factor: 2.872

7.  Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma.

Authors:  Mark Bi; Siming Zhao; Jonathan W Said; Maria J Merino; Adebowale J Adeniran; Zuoquan Xie; Cayce B Nawaf; Jaehyuk Choi; Arie S Belldegrun; Allan J Pantuck; Harriet M Kluger; Kaya Bilgüvar; Richard P Lifton; Brian Shuch
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-10       Impact factor: 11.205

8.  Does postoperative radiation therapy impact survival in non-metastatic sarcomatoid renal cell carcinoma? A SEER-based study.

Authors:  Okyaz Eminaga; Ilgar Akbarov; Sebastian Wille; Udo Engelmann
Journal:  Int Urol Nephrol       Date:  2015-09-02       Impact factor: 2.370

9.  Histologic subtype impacts cancer-specific survival in patients with sarcomatoid-variant renal cell carcinoma treated surgically.

Authors:  Daniel P Nguyen; Antoni Vilaseca; Emily A Vertosick; Renato B Corradi; Karim A Touijer; Nicole E Benfante; Daniel D Sjoberg; Paul Russo
Journal:  World J Urol       Date:  2015-07-28       Impact factor: 4.226

10.  Clinicopathologic characteristics and prognostic factors of sarcomatoid renal cell carcinoma.

Authors:  Yi Yan; Longfei Liu; Jingyu Zhou; Liling Li; Yuan Li; Minfeng Chen; Long Wang; Wei He; Xiao Guan; Xiongbing Zu; Lin Qi
Journal:  J Cancer Res Clin Oncol       Date:  2014-09-02       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.